Skip to main content

Stock Ready For Big Move

Jindal Drilling reached a life-time high of Rs 950.00 in the stock market boom of the year 2007-08 and then entered a long-lasting downtrend that continued until in the week before the last. The share, after topping out at Rs 950 in 2007-08, entered a long-lasting bearish trend and did not even participate in the latest stock market boom that emerged from August, 2013, as it continued to lose even when most others were gaining after August, 2013. In the last eight years post the 2007-08 stock market boom, the share has formed sustainingly lower tops. Even in the latest stock market boom, it reached a high of Rs 302.75, which was the lowest top in the series. From the latest top of Rs 302.75 established in May, 2014, the share entered a sustained downtrend until it reached a low of Rs 105 on Tuesday of the previous week. However, after reaching this nine to ten years' low of Rs 105, the share rallied and rose to Rs 139.90 in just two working days of hitting the lowest. A technical correction sent it back to Rs 118 on Wednesday of the last week in intraday but before the markets closed it jumped to Rs 144 before closing at Rs 142.60. On Thursday, the share opened up with a bullish gap and rose to a high of Rs 164.80 before closing at Rs 159. Thus, the share has performed exceedingly bullish in the last couple of 7th September to 13th SMART INVESTMENT September 2015 10 trading sessions and closed higher than the preaks of many preceding days and therefore, most likely to attract fresh buying support that could take it further up in the days to come.

Comments

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...